Correspondence

Hot-Tub Therapy for Type 2 Diabetes Mellitus

N Engl J Med 1999; 341:924-925September 16, 1999

Article

To the Editor:

Physical exercise is effective therapy for patients with type 2 diabetes mellitus. Therefore, my colleagues and I asked the following question: Would the effects of partial immersion in a hot tub simulate the beneficial effects of exercise? We asked eight patients (five men and three women; age range, 43 to 68 years; mean [±SD] weight, 104.7±53.2 kg) to sit in a hot tub at an athletic facility with water up to their shoulders. They used the hot tub for 30 minutes a day, six days a week, for three weeks between September 1998 and April 1999 (Table 1Table 1Characteristics of the Eight Patients and Results of Three Weeks of Exposure to a Hot Tub.). The patients' diets, exercise routines, and therapy (three patients were taking insulin, and all were taking various oral hypoglycemic drugs) were stable for eight weeks before the study and while the study took place.

The temperature of the water in the tub ranged from 37.8°C to 41.0°C, and the patients' oral temperature rose an average of 0.8°C during each session. After 10 days, one patient reduced his dose of insulin by 18 percent to prevent hypoglycemic reactions. During the three-week period, the patients' weight decreased by a mean of 1.7±2.7 kg (P=0.08). Their mean fasting plasma glucose level decreased from 182±37 mg per deciliter (10.1±2.0 mmol per liter) to 159±42 mg per deciliter (8.8±2.3 mmol per liter) (P=0.02), and their mean glycosylated hemoglobin levels decreased from 11.3±3.1 percent to 10.3±2.6 percent (P=0.004).

When the water temperature was greater than 40°C, the patients reported feeling hot. Patients became dizzy on exiting the tub when they hurried to stand. Therefore, they were routinely helped from the tub and seated until they could safely walk. As the study progressed, they reported improved sleep and an increased general sense of well-being. Our results suggest that hot-tub therapy should be further evaluated as a therapy for patients with type 2 diabetes mellitus. It may be especially helpful for patients who are unable to exercise. The benefits could result from increased blood flow to skeletal muscles.1

Philip L. Hooper, M.D.
McKee Medical Center, Loveland, CO 80537

1 References

1. 1

   Baron AD, Steinberg H, Brechtel G, Johnson A. Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am J Physiol 1994;266:E248-E253
   Web of Science | Medline

Citing Articles (17)

Citing Articles

1. 1

   Josianne Rodrigues-Krause, Mauricio Krause, C. O’Hagan, Giuseppe Vito, Colin Boreham, Colin Murphy, Philip Newsholme, Gerard Colleran. (2012) Divergence of intracellular and extracellular HSP72 in type 2 diabetes: does fat matter?. Cell Stress and Chaperones
   CrossRef

2. 2

   Mihály Oláh, Ágnes Koncz, Judit Fehér, Judit Kálmánczhey, Csaba Oláh, György Nagy, Tamás Bender. (2011) The effect of balneotherapy on antioxidant, inflammatory, and metabolic indices in patients with cardiovascular risk factors (hypertension and obesity)—A randomised, controlled, follow-up study. Contemporary Clinical Trials 32:6, 793-801
   CrossRef

3. 3

   Megumi Shimodozono, Shuji Matsumoto, Koji Ninomiya, Ryuji Miyata, Atsuko Ogata, Seiji Etoh, Satoshi Watanabe, Kazumi Kawahira. (2011) Acute effects of a single warm-water bath on serum adiponectin and leptin levels in healthy men: A pilot study. International Journal of Biometeorology
   CrossRef

4. 4

   Mauro B. Almeida, José Luiz Martins do Nascimento, Anderson Manoel Herculano, Maria Elena Crespo-López. (2011) Molecular chaperones: Toward new therapeutic tools. Biomedicine & Pharmacotherapy 65:4, 239-243
   CrossRef

5. 5

   Paige C. Geiger, Anisha A. Gupte. (2011) Heat Shock Proteins Are Important Mediators of Skeletal Muscle Insulin Sensitivity. Exercise and Sport Sciences Reviews 39:1, 34-42
   CrossRef

6. 6

   J. Chung, A.-K. Nguyen, D. C. Henstridge, A. G. Holmes, M. H. S. Chan, J. L. Mesa, G. I. Lancaster, R. J. Southgate, C. R. Bruce, S. J. Duffy, I. Horvath, R. Mestril, M. J. Watt, P. L. Hooper, B. A. Kingwell, L. Vigh, A. Hevener, M. A. Febbraio. (2008) HSP72 protects against obesity-induced insulin resistance. Proceedings of the National Academy of Sciences 105:5, 1739-1744
   CrossRef

7. 7

   K Pilkington, E Stenhouse, G Kirkwood, J Richardson. (2007) Diabetes and complementary therapies: mapping the evidence. Practical Diabetes International 24:7, 371-376
   CrossRef

8. 8

   Philip L. Hooper. (2007) Insulin Signaling, GSK-3, Heat Shock Proteins and the Natural History of Type 2 Diabetes Mellitus: A Hypothesis. Metabolic Syndrome and Related Disorders 5:3, 220-230
   CrossRef

9. 9

   Shefali Dham, Viral Shah, Sondra Hirsch, Mary Ann Banerji. (2006) The role of complementary and alternative medicine in diabetes. Current Diabetes Reports 6:3, 251-258
   CrossRef

10. 10

    Csaba Sõti, Enikõ Nagy, Zoltán Giricz, László Vígh, Péter Csermely, Péter Ferdinandy. (2005) Heat shock proteins as emerging therapeutic targets. British Journal of Pharmacology 146:6, 769-780
    CrossRef

11. 11

    Làszló Vigh, Pablo V. Escribá, Alois Sonnleitner, Max Sonnleitner, Stefano Piotto, Bruno Maresca, Ibolya Horváth, John L. Harwood. (2005) The significance of lipid composition for membrane activity: New concepts and ways of assessing function. Progress in Lipid Research 44:5, 303-344
    CrossRef

12. 12

    Trisha Dunning, Michelle Robins. 2005. Resources. , 283-286.
    CrossRef

13. 13

    W. A. Lai, C.-Y. Lew-Ting, W.-C. Chie. (2005) How diabetic patients think about and manage their illness in Taiwan. Diabetic Medicine 22:3, 286-292
    CrossRef

14. 14

    Philip L. Hooper, Joanna J. Hooper. (2005) Loss of Defense Against Stress: Diabetes and Heat Shock Proteins. Diabetes Technology & Therapeutics 7:1, 204-208
    CrossRef

15. 15

    Masakazu Imamura, Sadatoshi Biro, Takashi Kihara, Shiro Yoshifuku, Kunitsugu Takasaki, Yutaka Otsuji, Shinichi Minagoe, Yoshifumi Toyama, Chuwa Tei. (2001) Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors. Journal of the American College of Cardiology 38:4, 1083-1088
    CrossRef

16. 16

    Michael Tytell1, Philip L Hooper. (2001) Heat shock proteins: new keys to the development of cytoprotective therapies. Expert Opinion on Therapeutic Targets 5:2, 267-287
    CrossRef

17. 17

    (2000) Hot-Tub Therapy for Type 2 Diabetes Mellitus. New England Journal of Medicine 342:3, 218-219
    Full Text

Letters